Credit Suisse Group Analysts Give Vivendi (EPA:VIV) a €29.30 Price Target

Credit Suisse Group set a €29.30 ($34.07) price objective on Vivendi (EPA:VIV) in a report issued on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Several other research firms have also recently issued reports on VIV. JPMorgan Chase & Co. set a €38.00 ($44.19) price objective on shares of Vivendi and gave the stock a buy rating in a research report on Friday, March 20th. Morgan Stanley set a €31.00 ($36.05) price objective on shares of Vivendi and gave the stock a buy rating in a research report on Friday, February 14th. UBS Group set a €32.00 ($37.21) price objective on shares of Vivendi and gave the stock a buy rating in a research report on Friday, February 14th. Kepler Capital Markets set a €26.00 ($30.23) price objective on shares of Vivendi and gave the stock a buy rating in a research report on Monday, March 9th. Finally, Barclays set a €24.00 ($27.91) price objective on shares of Vivendi and gave the stock a buy rating in a research report on Monday. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of €30.26 ($35.19).

Vivendi stock opened at €19.27 ($22.41) on Monday. The company has a fifty day simple moving average of €22.76 and a 200-day simple moving average of €24.53. Vivendi has a 12-month low of €16.85 ($19.59) and a 12-month high of €24.87 ($28.92).

About Vivendi

Vivendi SA operates as a content media and communication company in France, rest of Europe, the Americas, Asia/Oceania, and Africa. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment engages in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provision of artist and merchandising services.

Recommended Story: Market Timing – The Benefits and the Danger

Analyst Recommendations for Vivendi (EPA:VIV)

Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.